Earlier in December, the US Food and Drug Administration's Vaccine Advisory Committee recommended Moderna's coronavirus vaccine candidate for emergency use authorization. The Moderna vaccine is the second coronavirus vaccine greenlighted by the advisory committee, after Pfizer and BioNTech COVID-19 vaccine.